Who owns PMV Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PMVP from SEC Form 13F filings across 64 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 64 institutions disclosed 34.3M shares of PMV Pharmaceuticals, Inc. worth $45.9M — about 64.2% of shares outstanding; the largest disclosed holder is BML Capital Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
64
13F holders
$45.9M
value, 2026 filers
64.2%
of shares outstanding (34.3M sh)
4
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of PMVP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BML Capital Management, LLC | 5.3M | $7.1M | 4.1% | 10% | +0.2% |
| 2 | TANG CAPITAL MANAGEMENT LLC | 4.2M | $5.7M | 0.3% | 8% | 0.0% |
| 3 | Sio Capital Management, LLC | 2.6M | $3.5M | 0.6% | 4.9% | -14.4% |
| 4 | Euclidean Capital LLC | 2.6M | $3.5M | 0.8% | 4.9% | 0.0% |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.4M | $3.2M | 0.0% | 4.4% | +26.9% |
| 6 | ACADIAN ASSET MANAGEMENT LLC | 2.2M | $3.0M | 0.0% | 4.2% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $2.7M | 0.0% | 3.8% | +1.9% |
| 8 | ArrowMark Colorado Holdings LLC | 2.0M | $2.6M | 0.1% | 3.7% | -31.8% |
| 9 | TWO SIGMA INVESTMENTS, LP | 2.0M | $2.6M | 0.0% | 3.7% | +3.7% |
| 10 | Eversept Partners, LP | 1.9M | $2.5M | 0.1% | 3.5% | -19.5% |
| 11 | BlackRock, Inc. | 919,818 | $1.2M | 0.0% | 1.7% | +5.2% |
| 12 | Stonepine Capital Management, LLC | 536,086 | $718,355 | 0.4% | 1% | -24.3% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 473,158 | $634,624 | 0.0% | 0.9% | -4.6% |
| 14 | Aldebaran Capital, LLC | 467,432 | $626,359 | 0.5% | 0.9% | -1.3% |
| 15 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 428,853 | $574,663 | 0.0% | 0.8% | 0.0% |
| 16 | BIT Capital GmbH | 407,555 | $546,124 | 0.0% | 0.8% | +229.9% |
| 17 | Verdad Advisers, LP | 362,361 | $485,564 | 0.5% | 0.7% | +101.1% |
| 18 | Walleye Capital LLC | 335,694 | $449,830 | 0.0% | 0.6% | 0.0% |
| 19 | Assenagon Asset Management S.A. | 330,003 | $442,204 | 0.0% | 0.6% | -8.5% |
| 20 | MARSHALL WACE, LLP | 321,610 | $430,956 | 0.0% | 0.6% | -25.9% |
| 21 | VANGUARD FIDUCIARY TRUST CO | 254,775 | $341,399 | 0.0% | 0.5% | -14.5% |
| 22 | BANK OF AMERICA CORP /DE/ | 240,110 | $321,747 | 0.0% | 0.4% | -0.2% |
| 23 | ADAR1 Capital Management, LLC | 201,008 | $269,351 | 0.0% | 0.4% | -13.0% |
| 24 | STATE STREET CORP | 183,178 | $245,459 | 0.0% | 0.3% | 0.0% |
| 25 | RBF Capital, LLC | 162,200 | $217,348 | 0.0% | 0.3% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.